Physical Fitness Training in Subacute Stroke (PHYS-Stroke)

June 4, 2019 updated by: Agnes Flöel, Charite University, Berlin, Germany
The aim of this study is to investigate whether a 4-week physical fitness training (target intervention) in stroke patients (subacute stage) increase the walking speed and activities of daily living compared with a control intervention (relaxation exercises). The target or control intervention is performed in addition to standard rehabilitation treatment.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 12351
        • Vivantes Klinikum Neukölln
      • Berlin, Germany, 10117
        • Charité - Universitätsmedizin Berlin
      • Berlin, Germany, 12200
        • Charite Campus Benjamin Franklin
      • Berlin, Germany, 13347
        • Evanglisches Geriatriezentrum Berlin
      • Berlin, Germany, 13507
        • Medical Park Berlin
    • Brandenburg
      • Beelitz Heilstatten, Brandenburg, Germany, 14547
        • Beelitz Heilstätten
      • Grunheide, Brandenburg, Germany, 15537
        • Median Klinik Grünheide

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria for patients:

  • diagnosis of stroke within 5-45 days after stroke
  • age >= 18 years
  • able to sit for at least 30 seconds
  • Barthel index < =65 at inclusion
  • considered able to perform aerobic exercise as determined by responsible physician
  • Written informed consent of the patient

Exclusion Criteria:

  • Patient considered unable to comply with study requirements
  • stroke due to intracranial hemorrhage primarily due to bleeding from ruptured aneurysm or arteriovenous malformation
  • patients with progressive stroke
  • unable to perfom the required exercises due to

    1. medical problems
    2. musculo-skeletal problems
    3. neurological problems
  • required help to at least 1 persons to walk before stroke due to neurological or non-neurological co-morbidities
  • life expectancy of less than 1 year as determined by responsible physician
  • alcohol or drug addiction within the last 6 months
  • significant current psychiatric illness as defined as medication-refractory of bipolar affective disorder, psychosis, schizophrenia or suicidality
  • current participation in another intervention study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: physical fitness training
aerobic physical fitness training
Active Comparator: relaxation
non-aerobic training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait speed and Barthel Index (BI) (co-primary endpoint)
Time Frame: 3 months post stroke vs baseline
comparing gait speed (m/s) and points achieved in BARTHEL Index in aerobic and non-aroebic training group 3 months after stroke vs baseline (before intervention)
3 months post stroke vs baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait speed and Barthel Index (BI)
Time Frame: directly after intervention; 6 months post stroke; all vs baseline
comparing gait speed (m/s) and points achieved in BI in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 6 months post stroke vs baseline (before intervention)
directly after intervention; 6 months post stroke; all vs baseline
motor function
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing motor function (assessed via different clinical scales e.g. Rivermead Arm test, REPAS, Box and Block Test, Medical Research Council Scale) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
mobility
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing different mobilitiy indices like gait endurance (in min), stride length, step cadence, use of walking aids, actigraph measurements and the Rivermead mobility Index in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
cognitive function
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing cognitive function (assessed via points achieved in different scales, e.g. Montreal Cognitive Assessment, Trail Making test, word fluency) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
Disability
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing disability (Modified rankin scale) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
Quality of life (QoL)
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing QoL (EQ-5D-5L scale) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
sleep
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing sleep quality (Pittsburgh sleep quality index) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
mood
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing mood (CES-D scale) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
Physical fitness
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke, all vs baseline
comparing gait energy Expenditure in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke, all vs baseline
Assessment of safety
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing different criteria (recurrent fatal or non-fatal cardiovascular or cerebrovascular events, refferal to acute hospital, death) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
Maximal walking speed and Barthel-Index
Time Frame: 3 months post stroke vs. baseline
per Protocol analysis of co-primary endpoint (pre-specified in statistical analysis plan and protocol)
3 months post stroke vs. baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
resting systolic and diastolic blood pressure
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke, all vs baseline
comparing resting systolic and diastolic blood pressure (mmHg) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke, all vs baseline
laboratory parameters
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing different laboratory parameters (derived by blood draw) like hormones, hemogram, liver and kidney function, and coagulation parameters in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
hair cortisol concentration
Time Frame: at baseline
hair cortisol concentration by taking a small strand of hair is measured at baseline; part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
at baseline
resting heart rate
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comaparing resting heart rate(beats/minute) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
waist to hip ratio
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing waist to hip ratio (cm) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
markers of peripheral immunity
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comapring markers of peripheral immunity (e.g., monocytic HLA-DR expression) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
lipid profile
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing lipide such as triglycerides, cholesterol (total, LDL,HDL, and LP(a)) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
blood glucose
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing insulin, glucose, and HbA1c in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
markers of inflammation
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing markers of inflammation (e.g., including Interleukin (IL) 6, 1b, hs-CRP) in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
body mass index
Time Frame: directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
comparing body mass index in aerobic and non-aroebic training group after the 4-week intervention interval as well as after 3 and after 6 months post stroke vs baseline (before intervention); part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention; 3 months post stroke; 6 months post stroke; all vs baseline
Endothelial function
Time Frame: directly after intervention vs. baseline
the endothelial function of included patients will be assessed prospectively before and after the 4 week intervention with the Endopat2000 device. First measurement was conducted in January 11th 2014. Results will be correlated with imaging and blood-derived biomarkers as well as differences between intervention groups; part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention vs. baseline
Magnetic resonance imaging parameters
Time Frame: directly after intervention vs. baseline
Primary and secondary endpoints are specified after completion of the interim analysis after inclusion of the first 24 patients (first stage). In a second stage the study is conducted with specified primary and secondary endpoints with recruitment of up to 76 remaining patients; part of substudy 'Biomarkers and Perfusion - Training-Induced Changes After Stroke (BAPTISe)' - NCT01954797 (will be analyzed seperately)
directly after intervention vs. baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Actual)

July 6, 2017

Study Completion (Actual)

November 1, 2017

Study Registration Dates

First Submitted

June 28, 2013

First Submitted That Met QC Criteria

September 26, 2013

First Posted (Estimate)

October 1, 2013

Study Record Updates

Last Update Posted (Actual)

June 6, 2019

Last Update Submitted That Met QC Criteria

June 4, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Study Data/Documents

  1. Statistical Analysis Plan
    Information comments: Statistical Analysis Plan of PHYS-Stroke Trial. If download path is offline please contact torsten.rackoll@charite.de

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on physical fitness training

Subscribe